Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development

The thymus plays a fundamental role in establishing and maintaining central and peripheral tolerance and defects in thymic architecture or AIRE expression result in the development of autoreactive lymphocytes. Patients with partial DiGeorge Syndrome (pDGS) and Down Syndrome (DS) present alterations...

Full description

Bibliographic Details
Main Authors: Genni Enza Marcovecchio, Ileana Bortolomai, Francesca Ferrua, Elena Fontana, Luisa Imberti, Erika Conforti, Donato Amodio, Sonia Bergante, Giulia Macchiarulo, Veronica D'Oria, Francesca Conti, Silvia Di Cesare, Georgia Fousteri, Adriano Carotti, Alessandro Giamberti, Pietro Luigi Poliani, Luigi D. Notarangelo, Caterina Cancrini, Anna Villa, Marita Bosticardo
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.00447/full
id doaj-a45773a2330e4a0eb3500a223a4c3747
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Genni Enza Marcovecchio
Genni Enza Marcovecchio
Ileana Bortolomai
Ileana Bortolomai
Francesca Ferrua
Francesca Ferrua
Francesca Ferrua
Elena Fontana
Elena Fontana
Luisa Imberti
Erika Conforti
Donato Amodio
Donato Amodio
Sonia Bergante
Giulia Macchiarulo
Giulia Macchiarulo
Veronica D'Oria
Francesca Conti
Silvia Di Cesare
Georgia Fousteri
Adriano Carotti
Alessandro Giamberti
Pietro Luigi Poliani
Luigi D. Notarangelo
Caterina Cancrini
Caterina Cancrini
Anna Villa
Anna Villa
Marita Bosticardo
Marita Bosticardo
spellingShingle Genni Enza Marcovecchio
Genni Enza Marcovecchio
Ileana Bortolomai
Ileana Bortolomai
Francesca Ferrua
Francesca Ferrua
Francesca Ferrua
Elena Fontana
Elena Fontana
Luisa Imberti
Erika Conforti
Donato Amodio
Donato Amodio
Sonia Bergante
Giulia Macchiarulo
Giulia Macchiarulo
Veronica D'Oria
Francesca Conti
Silvia Di Cesare
Georgia Fousteri
Adriano Carotti
Alessandro Giamberti
Pietro Luigi Poliani
Luigi D. Notarangelo
Caterina Cancrini
Caterina Cancrini
Anna Villa
Anna Villa
Marita Bosticardo
Marita Bosticardo
Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development
Frontiers in Immunology
thymus
DiGeorge syndrome
Down syndrome
regulatory T (Treg) cells
thymocytes
author_facet Genni Enza Marcovecchio
Genni Enza Marcovecchio
Ileana Bortolomai
Ileana Bortolomai
Francesca Ferrua
Francesca Ferrua
Francesca Ferrua
Elena Fontana
Elena Fontana
Luisa Imberti
Erika Conforti
Donato Amodio
Donato Amodio
Sonia Bergante
Giulia Macchiarulo
Giulia Macchiarulo
Veronica D'Oria
Francesca Conti
Silvia Di Cesare
Georgia Fousteri
Adriano Carotti
Alessandro Giamberti
Pietro Luigi Poliani
Luigi D. Notarangelo
Caterina Cancrini
Caterina Cancrini
Anna Villa
Anna Villa
Marita Bosticardo
Marita Bosticardo
author_sort Genni Enza Marcovecchio
title Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development
title_short Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development
title_full Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development
title_fullStr Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development
title_full_unstemmed Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development
title_sort thymic epithelium abnormalities in digeorge and down syndrome patients contribute to dysregulation in t cell development
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2019-03-01
description The thymus plays a fundamental role in establishing and maintaining central and peripheral tolerance and defects in thymic architecture or AIRE expression result in the development of autoreactive lymphocytes. Patients with partial DiGeorge Syndrome (pDGS) and Down Syndrome (DS) present alterations in size and architecture of the thymus and higher risk to develop autoimmunity. We sought to evaluate thymic architecture and thymocyte development in DGS and DS patients and to determine the extent to which thymic defects result in immune dysregulation and T cell homeostasis perturbation in these patients. Thymi from pediatric patients and age-matched controls were obtained to evaluate cortex and medullary compartments, AIRE expression and thymocyte development. In the same patients we also characterized immunophenotype of peripheral T cells. Phenotypic and functional characterization of thymic and peripheral regulatory T (Treg) cells was finally assessed. Histologic analysis revealed peculiar alterations in thymic medulla size and maturation in DGS and DS patients. Perturbed distribution of thymocytes and altered thymic output was also observed. DGS patients showed lower mature CD4+ and CD8+ T cell frequency, associated with reduced proportion and function of Tregs both in thymus and peripheral blood. DS patients showed increased frequency of single positive (SP) thymocytes and thymic Treg cells. However, Tregs isolated both from thymus and peripheral blood of DS patients showed reduced suppressive ability. Our results provide novel insights on thymic defects associated with DGS and DS and their impact on peripheral immune dysregulation. Indeed, thymic abnormalities and defect in thymocyte development, in particular in Treg cell number and function could contribute in the pathogenesis of the immunodysregulation present in pDGS and in DS patients.
topic thymus
DiGeorge syndrome
Down syndrome
regulatory T (Treg) cells
thymocytes
url https://www.frontiersin.org/article/10.3389/fimmu.2019.00447/full
work_keys_str_mv AT gennienzamarcovecchio thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT gennienzamarcovecchio thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT ileanabortolomai thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT ileanabortolomai thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT francescaferrua thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT francescaferrua thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT francescaferrua thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT elenafontana thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT elenafontana thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT luisaimberti thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT erikaconforti thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT donatoamodio thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT donatoamodio thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT soniabergante thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT giuliamacchiarulo thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT giuliamacchiarulo thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT veronicadoria thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT francescaconti thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT silviadicesare thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT georgiafousteri thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT adrianocarotti thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT alessandrogiamberti thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT pietroluigipoliani thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT luigidnotarangelo thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT caterinacancrini thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT caterinacancrini thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT annavilla thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT annavilla thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT maritabosticardo thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
AT maritabosticardo thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment
_version_ 1724890569947217920
spelling doaj-a45773a2330e4a0eb3500a223a4c37472020-11-25T02:16:33ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-03-011010.3389/fimmu.2019.00447417059Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell DevelopmentGenni Enza Marcovecchio0Genni Enza Marcovecchio1Ileana Bortolomai2Ileana Bortolomai3Francesca Ferrua4Francesca Ferrua5Francesca Ferrua6Elena Fontana7Elena Fontana8Luisa Imberti9Erika Conforti10Donato Amodio11Donato Amodio12Sonia Bergante13Giulia Macchiarulo14Giulia Macchiarulo15Veronica D'Oria16Francesca Conti17Silvia Di Cesare18Georgia Fousteri19Adriano Carotti20Alessandro Giamberti21Pietro Luigi Poliani22Luigi D. Notarangelo23Caterina Cancrini24Caterina Cancrini25Anna Villa26Anna Villa27Marita Bosticardo28Marita Bosticardo29Division of Regenerative Medicine, Stem Cells and Gene Therapy, Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, ItalyDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyDivision of Regenerative Medicine, Stem Cells and Gene Therapy, Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, ItalyThe Milan Unit, Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Milan, ItalyDivision of Regenerative Medicine, Stem Cells and Gene Therapy, Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, ItalyVita-Salute San Raffaele University, Milan, ItalyPediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, ItalyThe Milan Unit, Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Milan, ItalyHumanitas Clinical and Research Center, Rozzano, Milan, ItalyLaboratorio CREA (Centro di Ricerca Emato-oncologica AIL), ASST Spedali Civili of Brescia, Brescia, ItalyDepartment of Pediatric Cardiac Surgery, IRCCS San Donato Milanese Hospital, San Donato Milanese, Milan, ItalyDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyUniversity Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy0Laboratory of Stem Cells for Tissue Engineering, Istituto di Ricovero e Cura a Carattere Scientifico, Policlinico San Donato, Milan, ItalyDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyUniversity Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, ItalyDepartment of Pediatric Cardiac Surgery, IRCCS San Donato Milanese Hospital, San Donato Milanese, Milan, ItalyUniversity Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, ItalyDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, Italy1Division of Immunology Transplantation and Infectious Diseases, Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy2Department of Pediatric Cardiac Surgery, IRCCS Bambino Gesú Children's Hospital, Rome, Italy3Department of Congenital Cardiac Surgery, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy4Pathology Unit, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy5Laboratory of Clinical Immunology and Microbiology, IDGS, DIR, NIAID, NIH, Bethesda, MD, United StatesDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyUniversity Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, ItalyDivision of Regenerative Medicine, Stem Cells and Gene Therapy, Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, ItalyThe Milan Unit, Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Milan, ItalyDivision of Regenerative Medicine, Stem Cells and Gene Therapy, Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy5Laboratory of Clinical Immunology and Microbiology, IDGS, DIR, NIAID, NIH, Bethesda, MD, United StatesThe thymus plays a fundamental role in establishing and maintaining central and peripheral tolerance and defects in thymic architecture or AIRE expression result in the development of autoreactive lymphocytes. Patients with partial DiGeorge Syndrome (pDGS) and Down Syndrome (DS) present alterations in size and architecture of the thymus and higher risk to develop autoimmunity. We sought to evaluate thymic architecture and thymocyte development in DGS and DS patients and to determine the extent to which thymic defects result in immune dysregulation and T cell homeostasis perturbation in these patients. Thymi from pediatric patients and age-matched controls were obtained to evaluate cortex and medullary compartments, AIRE expression and thymocyte development. In the same patients we also characterized immunophenotype of peripheral T cells. Phenotypic and functional characterization of thymic and peripheral regulatory T (Treg) cells was finally assessed. Histologic analysis revealed peculiar alterations in thymic medulla size and maturation in DGS and DS patients. Perturbed distribution of thymocytes and altered thymic output was also observed. DGS patients showed lower mature CD4+ and CD8+ T cell frequency, associated with reduced proportion and function of Tregs both in thymus and peripheral blood. DS patients showed increased frequency of single positive (SP) thymocytes and thymic Treg cells. However, Tregs isolated both from thymus and peripheral blood of DS patients showed reduced suppressive ability. Our results provide novel insights on thymic defects associated with DGS and DS and their impact on peripheral immune dysregulation. Indeed, thymic abnormalities and defect in thymocyte development, in particular in Treg cell number and function could contribute in the pathogenesis of the immunodysregulation present in pDGS and in DS patients.https://www.frontiersin.org/article/10.3389/fimmu.2019.00447/fullthymusDiGeorge syndromeDown syndromeregulatory T (Treg) cellsthymocytes